Search Results for: PURA
Puma Biotechnology, Inc. (NYSE: PBYI) recently filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. No pricing details were announced, except that the offering would...
Published:
Last Updated:
Shares of Puma Biotechnology had a strong gain in Tuesday’s session following some positive news from the FDA on the company's breast cancer treatment.
Published:
Last Updated:
Panera Bread Company (NASDAQ: PNRA) is issuing some mixed guidance this morning, although shares are reacting favorably to the news. The company is increasing its second quarter 2008 earnings...
Published:
Source: ThinkstockFitch Ratings this morning cut its rating on Italian debt one notch from ‘A-’ to ‘BBB+’ with a negative outlook. And the ratings firm gave a long list of reasons for the...
Published:
Last Updated:
Kura Oncology saw its shares double early Friday after the firm announced results from its mid-stage trial in patients with squamous cell carcinomas.
Published:
Last Updated:
Oppenheimer has started coverage several of the casual dining chains this morning. Buffalo Wild Wings (BWLD) was initiated as an “Outperform” rating, with a 40% implied upside at a $52.00 price...
Published:
Last Updated:
After U.S. markets close on Wednesday, these four tech firms are scheduled to release quarterly earnings results.
Published:
Here is a look at what analysts expect when these four companies release quarterly results after U.S. markets close on Wednesday.
Published:
Four enterprise technology firms are reporting quarterly results after markets close Wednesday, including one Dow Jones industrial average component.
Published:
Kura Oncology is offering $60 million worth of shares in its initial public offering at an expected $16 per share.
Published:
Puma Biotechnology posted strong gains over the course of this past week, which began with some positive news from the FDA and continued with a huge analyst call.
Published:
Last Updated:
Puma Biotechnology watched its shares make a handy gain on Friday morning after the firm released updated results from its late-stage breast cancer trial.
Published:
Last Updated: